홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Hydroxide → 1-[3-(4-Chloro-phenyl)-[1,2,4]thiadiazol-5-yl]-4-[2-(4-methoxy-phenyl)-1-methyl-ethyl]-piperazine

HRID 570572
인쇄

반응식

HRID 570572 반응식
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[N:12]=[C:11]([N:13]3[CH2:18][CH2:17][NH:16][CH2:15][CH2:14]3)[S:10][N:9]=2)=[CH:4][CH:3]=1.[CH3:19][O:20][C:21]1[CH:26]=[CH:25][C:24]([CH2:27][C:28]([C:30]2C=CC=CC=2)=O)=[CH:23][CH:22]=1.[BH4-].[Na+].[OH-].[Na+]>C1COCC1.[Ti].CCOC(C)=O.O.CO>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[N:12]=[C:11]([N:13]3[CH2:18][CH2:17][N:16]([CH:28]([CH3:30])[CH2:27][C:24]4[CH:25]=[CH:26][C:21]([O:20][CH3:19])=[CH:22][CH:23]=4)[CH2:15][CH2:14]3)[S:10][N:9]=2)=[CH:4][CH:3]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 4

HCID 14798Sodium HydroxideHCID 2310922-(4-Methoxyphenyl)-1-phenylethan-1-oneHCID 4311764Sodium borohydrideHCID 577122563-(4-Chlorophenyl)-5-(piperazin-1-yl)-1,2,4-thiadiazole

생성물 1

HCID 711864501-[3-(4-Chloro-phenyl)-[1,2,4]thiadiazol-5-yl]-4-[2-(4-methoxy-phenyl)-1-methyl-ethyl]-piperazine

시약·촉매·용매 5

HCID 23963
Titanium
촉매
HCID 887Methanol용매
HCID 962Water용매
HCID 8028Tetrahydrofuran용매
HCID 8857Ethyl Acetate용매

실험 절차

A mixture of 3-(4-chlorophenyl)-5-(piperazin-1-yl)-1,2,4-thiadiazole (100 mg, 356 μmol), 4-methoxyphenylacetophenone (64.3 mg, 392 μmol) and titanium IV propoxide (152 mg, 158 μl, 534 μmol) in 2 mL THF was stirred for 3 h at RT. NaBH4 (40.4 mg, 1.07 mmol) was added in three portions. MeOH (0.2 mL) was added and stirred over the weekend at RT. Water (5 mL), EtOAc (10 mL) and aq. 2N NaOH (3 mL) was added, stirred for 10 min and filtered over a dicalit-plug. The aqueous layer was separated and extracted once with EtOAc (20 mL). The organic layers were washed with brine (1×20 mL), dried over Na2SO4, filtered off and concentrated in vacuo. The residue was purified by column chromatography on silica eluting with a gradient formed from heptane and EtOAc and again with preparative HPLC to yield, after evaporation of the product containing fraction, 39 mg (25%) of the title compound as off-white solid. MS (m/e): 429.2 (MH+).

후처리

  1. stirringstirred over the weekend at RT
  2. stirringstirred for 10 min
  3. filtrationfiltered over a dicalit-plug
  4. customThe aqueous layer was separated
  5. extractionextracted once with EtOAc (20 mL)
  6. washThe organic layers were washed with brine (1×20 mL)
  7. dry with materialdried over Na2SO4
  8. filtrationfiltered off
  9. concentrationconcentrated in vacuo
  10. customThe residue was purified by column chromatography on silica eluting with a gradient
  11. customformed from heptane and EtOAc and again with preparative HPLC
  12. customto yield
  13. customafter evaporation of the product
  14. additioncontaining fraction, 39 mg (25%) of the title compound as off-white solid

출처 및 근거

ORD 기록
ord-a97133ec86884350850eda196d8f8e89
출처 데이터셋
uspto-grants-2015_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09023852B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트